EUVIMEDEUVIMED entdecken
Crossref

Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment

Ashraf Zedan

SECI Oncology · 2014

DOI: 10.18056/seci2014.6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SECI Oncology, 2014. Verfasst von Ashraf Zedan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zedan, A. (2014). Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment. SECI Oncology. https://doi.org/10.18056/seci2014.6

Vancouver

Zedan A. Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment. SECI Oncology. 2014. doi:10.18056/seci2014.6

BibTeX
@article{Zedan2014,
  author = {Zedan, Ashraf},
  title = {Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment},
  journal = {SECI Oncology},
  year = {2014},
  doi = {10.18056/seci2014.6}
}
Kostenlos starten →